Dexamethasone for Migraine - Dose Comparison

• Status: Recruiting
• Trial end date: 2022-07-27
• Target enrollment: 0
• Participant gender: All

Summary

Dexamethasone is an evidence-based treatment of acute migraine. This is a randomized comparison of two different doses of dexamethasone for acute migraine.

All patients will also be treated with metoclopramide.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Montefiore Medical Center
• Treatments: BB 1101; Dexamethasone; Dexamethasone acetate

Criteria

Inclusion Criteria:

• Moderate or severe migraine

Exclusion Criteria:

• Medication contra-indication

• Concern for secondary cause of headache